(Q43612181)

25 November 2017

Lipid modulation in insulin-dependent diabetes mellitus: effect on microvascular outcomes (English)

1 reference

25 November 2017

1 reference

0 references

6

Orchard TJ

1 reference

25 November 2017

Fried LF

1

1 reference

25 November 2017

Forrest KY

2

1 reference

25 November 2017

Ellis D

3

1 reference

25 November 2017

Chang Y

4

1 reference

25 November 2017

Silvers N

5

1 reference

25 November 2017

1 May 2001

1 reference

Journal of Diabetes and its Complications

25 November 2017

1 reference

25 November 2017

15

1 reference

25 November 2017

3

1 reference

25 November 2017

113-119

1 reference

Management of dyslipidemia in adults with diabetes. American Diabetes Association

25 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2801%2900140-4

7 January 2021

Treatment of diabetic neuropathy with clofibrate

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2801%2900140-4

7 January 2021

Predictors of microalbuminuria in individuals with IDDM. Pittsburgh Epidemiology of Diabetes Complications Study

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2801%2900140-4

7 January 2021

A three-year trial of atromid therapy in exudative diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2801%2900140-4

7 January 2021

Choice of urine sample predictive of microalbuminuria in patients with insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2801%2900140-4

7 January 2021

A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2801%2900140-4

7 January 2021

Systematic reviews and their roles in promoting evidence-based medicine in renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2801%2900140-4

7 January 2021

The effects of lipid lowering on diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2801%2900140-4

7 January 2021

Interactions of LDL and modified LDL with mesangial cells and matrix

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2801%2900140-4

7 January 2021

A double-blind controlled trial of clofibrate in the treatment of diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2801%2900140-4

7 January 2021

Treatment of Exudative Diabetic Retinopathy with Atromid- S

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2801%2900140-4

7 January 2021

Prognostic indicators in patients presenting with the nephrotic syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2801%2900140-4

7 January 2021

Differences in renal outcomes with ACE inhibitors in type 1 and type 2 diabetic patients: possible explanations

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2801%2900140-4

7 January 2021

Pathogenesis of diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2801%2900140-4

7 January 2021

Treatment of hyperlipidemia reduces glomerular injury in obese Zucker rats

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2801%2900140-4

7 January 2021

An alternative method of grading diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2801%2900140-4

7 January 2021

Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2801%2900140-4

7 January 2021

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2801%2900140-4

7 January 2021

Effect of intensive blood pressure control on the course of type 1 diabetic nephropathy. Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2801%2900140-4

7 January 2021

The progression of retinopathy over 2 years: the Pittsburgh Epidemiology of Diabetes Complications (EDC) Study

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2801%2900140-4

7 January 2021

Measuring subclinical neuropathy: does it relate to clinical neuropathy? Pittsburgh epidemiology of diabetes complications study-V

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2801%2900140-4

7 January 2021

Efficacy of captopril in postponing nephropathy in normotensive insulin dependent diabetic patients with microalbuminuria.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2801%2900140-4

7 January 2021

Relation between serum cholesterol and diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2801%2900140-4

7 January 2021

Renal function and insulin sensitivity during simvastatin treatment in type 2 (non-insulin-dependent) diabetic patients with microalbuminuria

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2801%2900140-4

7 January 2021

Effect of lipoproteins on cultured human mesangial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2801%2900140-4

7 January 2021

The Eating Pattern Assessment Tool: a simple instrument for assessing dietary fat and cholesterol intake

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2801%2900140-4

7 January 2021

LDL stimulates mesangial fibronectin production and chemoattractant expression

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2801%2900140-4

7 January 2021

Comparison of statins in hypertriglyceridemia

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2801%2900140-4

7 January 2021

Apolipoproteins and lipoprotein receptors in glomeruli in human kidney diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2801%2900140-4

7 January 2021

Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications Trial. The Diabetes Control and Complications (DCCT) Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2801%2900140-4

7 January 2021

Reduction of albumin excretion rate in normotensive microalbuminuric type 2 diabetic patients during long-term simvastatin treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2801%2900140-4

7 January 2021

Effects of pravastatin on lipid levels, in vitro oxidizability of non-HDL lipoproteins and microalbuminuria in IDDM patients

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2801%2900140-4

7 January 2021

10.1016/S1056-8727(01)00140-4

Identifiers

DOI

1 reference

25 November 2017

1 reference